Wu Pingan, Yuan Guoyan, Lu Zhaoqun, Yang Siyi, Zhu Honglei, Zhou Rumin, Wilson Wai Shing Ho, Cai Jifu, Raymond King Yin Tsang
Department of Otolaryngology Head and Neck Surgery,the University of Hong Kong-Shenzhen Hospital,Shenzhen,518053,China.
Department of Surgery,Division of Neurosurgery,the University of Hong Kong-Shenzhen Hospital.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 May;35(5):448-452. doi: 10.13201/j.issn.2096-7993.2021.05.015.
To summarize and analyze the effect of extracranial/intracranial vascular bypass in the treatment of internal carotid artery burst hemorrhage after radiotherapy for nasopharyngeal carcinoma(NPC). A retrospective analysis of the data of 9 patients with nasopharyngeal carcinoma and carotid artery blowout syndrome(CBS) who underwent extracranial/intracranial vascular bypass. Collected patient demographics, treatment course and dose of radiotherapy, analyze the effect of extracranial/intracranial vascular bypass on the prognosis of patients with internal carotid artery burst hemorrhage, including perioperative stroke and death, overall survival rate, and rebleeding rate. Nine patients were included in the study. The average age is 53.5 years. The pathological types were all non-keratinizing squamous cell carcinoma, undifferentiated, stage Ⅳ; 7 cases of local NPC recurrence, 2 cases of skull base osteonecrosis; all 9 cases had internal carotid artery hemorrhage, including 7 cases of petrous carotid artery and 2 cases of cervical carotid artery; 3 cases of typeⅠthreatened CBS(33.3%), 2 cases of type Ⅱ impending CBS(22.2%), and 4 cases of type Ⅲ acute CBS(44.45%). All patients underwent extracranial/intracranial vascular bypass surgery, and there were no perioperative deaths and strokes. The mean follow-up was 16.7 months. The median overall survival time of the patients was 22.1 months and the 90-day, 1-year and 2-year survival rates were 100.0%, 75.0% and 30.0%, respectively. Patients with internal carotid artery burst hemorrhage after radiotherapy for nasopharyngeal carcinoma can be safely treated by extracranial/intracranial vascular bypass surgery and obtain a longer survival rate.
总结分析颅外/颅内血管搭桥术治疗鼻咽癌(NPC)放疗后颈内动脉破裂出血的效果。对9例行颅外/颅内血管搭桥术的鼻咽癌合并颈动脉破裂综合征(CBS)患者的数据进行回顾性分析。收集患者人口统计学资料、放疗疗程及剂量,分析颅外/颅内血管搭桥术对颈内动脉破裂出血患者预后的影响,包括围手术期卒中及死亡情况、总生存率和再出血率。本研究纳入9例患者。平均年龄53.5岁。病理类型均为未分化非角化性鳞状细胞癌,Ⅳ期;局部鼻咽癌复发7例,颅底骨坏死2例;9例均有颈内动脉出血,其中岩骨段颈内动脉出血7例,颈段颈内动脉出血2例;Ⅰ型CBS(濒临破裂型)3例(33.3%),Ⅱ型CBS(即将破裂型)2例(22.2%),Ⅲ型急性CBS(破裂型)4例(44.45%)。所有患者均行颅外/颅内血管搭桥手术,围手术期无死亡及卒中发生。平均随访16.7个月。患者中位总生存时间为22.1个月,90天、1年和2年生存率分别为100.0%、75.0%和30.0%。鼻咽癌放疗后颈内动脉破裂出血患者行颅外/颅内血管搭桥手术可安全治疗并获得较长生存期。